Martin Dekker

Insider Reports History

Entity
Individual
Location
53 Frontage Road, Suite 301, Perryville III Corporate Park, Hampton, NJ
Signature
/s/ Martin Dekker
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin Dekker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bellerophon Therapeutics, Inc. VP of Engineering & Manufacturing Stock Options (Right to Buy) 50K $155K $3.10 Jun 7, 2023 Direct

Insider Reports Filed by Martin Dekker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLPH Bellerophon Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 VP of Engineering & Manufacturing
BLPH Bellerophon Therapeutics, Inc. Feb 10, 2023 1 $76K 4 Feb 14, 2023 VP OF ENGINEERING & MANUFACTUR
BLPH Bellerophon Therapeutics, Inc. Dec 9, 2022 3 -$7.29K 4 Dec 13, 2022 VP OF ENGINEERING & MANUFACTUR
BLPH Bellerophon Therapeutics, Inc. Jan 26, 2022 1 $0 4 Jan 28, 2022 VP OF ENGINEERING & MANUFACTUR